ATC Group: M01A Antiinflammatory and antirheumatic products, non-steroids

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01A in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids

Group M01A contents

Code Title
M01AA Butylpyrazolidines
M01AB Acetic acid derivatives and related substances
M01AC Oxicams
M01AE Propionic acid derivatives
M01AG Fenamates
M01AH Coxibs
M01AX Other antiinflammatory and antirheumatic agents, non-steroids

Active ingredients in M01A

Active Ingredient Description
Aceclofenac

Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.

Acemetacin

Acemetacin is a glycolic acid ester of indomethacin and the pharmacological activity resulting from acemetacin administration in man is derived from the presence of both acemetacin and indomethacin. The precise pharmacological mode of action of acemetacin is not known. However, unlike other NSAIDs, acemetacin is only a relatively weak inhibitor of prostaglandin synthetase.

Ampiroxicam
Benzydamine

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.

Bumadizone
Celecoxib

Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.

Chondroitin sulfate

Chondroitin sulfate belongs to the polysaccharide subgroup of glycosaminoglycans. Chondroitin sulfate is one of the main elements of the cartilage, which joins a central protein, forming what we know as proteoglycan, which is what gives the cartilage its mechanical and elastic properties.

Clofezone
Dexibuprofen

Dexibuprofen is considered to be the pharmacologically active enantiomer of racemic ibuprofen. Racemic ibuprofen is a non-steroidal substance with antiinflammatory and analgesic effects. Its mechanism of action is thought to be due to inhibition of prostaglandin synthesis.

Dexketoprofen

Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action.

Diacerein

Diacerein is an anthraquinone derivative which has moderate anti-inflammatory activity. It is anti-inflammatory at high doses and devoid of any irritant effect on the stomach.

Diclofenac

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

Etoricoxib

Etoricoxib is an oral, selective cyclo-oxygenase-2 (COX-2) inhibitor within the clinical dose range. Cyclooxygenase is responsible for generation of prostaglandins. Two isoforms, COX-1 and COX-2, have been identified. COX-2 is the isoform of the enzyme that has been shown to be induced by pro-inflammatory stimuli and has been postulated to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. COX-2 is also involved in ovulation, implantation and closure of the ductus arteriosus, regulation of renal function, and central nervous system functions (fever induction, pain perception and cognitive function). It may also play a role in ulcer healing. COX-2 has been identified in tissue around gastric ulcers in man but its relevance to ulcer healing has not been established.

Fenoprofen

Fernoprofen has analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of prostaglandin synthesis. Its mode of action may be due to a decrease of prostaglandins in peripheral tissues.

Flufenamic acid
Flurbiprofen

Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties.

Glucosamine

Glucosamine is an endogenous substance, a normal constituent of the polysaccharide chains of cartilage matrix and synovial fluid glucosaminoglycans. In vitro and in vivo studies have shown glucosamine stimulates the synthesis of physiological glycosaminoglycans and proteoglycans by chondrocytes and of hyaluronic acid by synoviocytes.

Ibuprofen

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.

Indometacin

Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.

Kebuzone
Ketoprofen

Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions.

Ketorolac

Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.

Lornoxicam

Lornoxicam is a non-steroidal anti-inflammatory drug with analgesic properties and belongs to the class of oxicams. Lornoxicams mode of action is mainly related to the inhibition of the prostaglandin synthesis (inhibition of the cyclooxygenase enzyme) leading to desensitisation of peripheral nociceptors and consequently inhibition of inflammation. A central effect on nociception, which seems to be independent of anti-inflammatory effects has also been suggested.

Meclofenamic acid
Mefenamic acid

Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties.

Meloxicam

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators.

Nabumetone

Nabumetone is a non acidic non steroidal anti-inflammatory agent with weak prostaglandin synthesis properties. Nabumetone undergoes rapid and extensive metabolism in the liver to 6-methoxy-2-naphthylacetic acid (6-MNA), the principal active metabolite which is a potent inhibitor of prostaglandin synthesis.

Naproxen

Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis.

Niflumic acid

Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Nimesulide

Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation.

Oxaceprol
Oxaprozin

Oxaprozin has analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of oxaprozin, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2).

Parecoxib

Parecoxib is a prodrug of valdecoxib. Valdecoxib is a selective COX-2 inhibitor within the clinical dose range. Cyclooxygenase is responsible for generation of prostaglandins. Two isoforms, COX-1 and COX-2, have been identified. COX-2 is the isoform of the enzyme that has been shown to be induced by pro-inflammatory stimuli and has been postulated to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever.

Piroxicam

Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.

Proglumetacin
Rofecoxib

Rofecoxib is a nonsteroidal anti-inflammatory drug that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. The mechanism of action of rofecoxib is believed to be due to inhibition of prostaglandin synthesis, via inhibition of cyclooxygenase-2 (COX-2).

Soybean oil, refined
Sulindac

Sulindac is a fluorinated indene with a structural resemblance to indometacin. It has analgesic, anti-inflammatory and antipyretic actions.

Suprofen
Tenoxicam

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) which has anti-inflammatory, analgesic, antipyretic properties and it also inhibits platelet aggregation.

Tiaprofenic acid

Tiaprofenic acid is a non-steroidal anti-inflammatory drug employed in the treatment of pain, especially arthritic pain. Results of in-vitro experiments and ex-vivo studies suggest a neutral or possibly beneficial effect of tiaprofenic acid on joint cartilage under experimental conditions.

Tolfenamic acid

Tolfenamic acid is a NSAID with anti-inflammatory, analgesic, and antipyretic effects. Tolfenamic acid is a prostaglandin synthesis inhibitor and a leukotriene synthesis inhibitor.

Valdecoxib

Valdecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic and antipyretic properties in animal models. The mechanism of action is believed to be due to inhibition of prostaglandin synthesis primarily through inhibition of cyclooxygenase-2 (COX-2).

Zaltoprofen

Related product monographs

Title Information Source Document Type  
ADVIL LIQUI-GELS Liquid capsule Health Products Regulatory Authority (ZA) MPI, Generic
AKIS Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ALEVE Caplet / Capsule / Tablet Health Products and Food Branch (CA) MPI, CA: SPM
ALFOXAN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ALFOXAN Hard capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
ALGIDRIN PEDIATRIC Oral suspension Medicines Authority (MT) MPI, EU: SmPC
ALMIRAL Gastro-resistant tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ALMIRAL Gel Υπουργείο Υγείας (CY) MPI, EU: SmPC
ALMIRAL Solution for injection / infusion Υπουργείο Υγείας (CY) MPI, EU: SmPC
ALMIRAL Suppositories Υπουργείο Υγείας (CY) MPI, EU: SmPC
APONIL Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ARCOXIA Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ARESTON Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ARTHREXIN Capsule Health Products Regulatory Authority (ZA) MPI, Generic
AULIN Gel Health Products Regulatory Authority (IE) MPI, EU: SmPC
BRUFEN Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
CALPROFEN Oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CAMBIA Powder for oral solution FDA, National Drug Code (US) MPI, US: SPL/PLR
CATAFAST Powder for oral solution Medicines Authority (MT) MPI, EU: SmPC
CATAFLAM Sugar coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
CELEBREX Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR
CELEBREX Capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CHONDROMEL Hard capsule Health Products Regulatory Authority (IE) MPI, EU: SmPC
CLOTAM RAPID Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CORICIB Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
DICLAC Enteric-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
DICLAC Solution for injection Υπουργείο Υγείας (CY) MPI, EU: SmPC
DICLOFLEX Prolonged-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DIFENE Modified‑release capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
DIFFLAM Lozenge Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DOLENIO Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DYNASTAT Powder for solution for injection European Medicines Agency (EU) MPI, EU: SmPC
ECOXAR Flm-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
ETORIAX Film-coated tablet MPI, EU: SmPC
FELDENE Capsule, FELDENE D Tablet Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
FENPAED Oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLAMARYX Tablet Health Products Regulatory Authority (ZA) MPI, Generic
IBUGESIC Film-coated tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
IBUPROFEN 400mg Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
IBUPROFEN 600mg Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
INDOCID Capsules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
INDOCID Suppositories Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
INDOREM Hard capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
INDYLON Hard gelatine capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
KERAL Film coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
KETESSE Film-coated tablets Health Products Regulatory Authority (ZA) MPI, Generic
LODINE SR Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MELCAM Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
MELOREX Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
MELOX Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MELOXICAM Orodispersible tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MESULID Tablet MPI, EU: SmPC
MOBIC Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
MOBIFLEX Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOTIFENE Capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOTIFINE Capsule, hard Health Products Regulatory Authority (ZA) MPI, Generic
MOTRIN Tablet Health Products and Food Branch (CA) MPI, CA: SPM
MOXICAM Tablet MPI, EU: SmPC
NAPROREX Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
NAPROSYN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NAPROSYN, EC-NAPROSYN, ANAPROX DS Tablet, Delayed-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
NIMM Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
NUROFEN Coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
NUROFEN PLUS Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
NUROMOL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OKITASK Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
ORUDIS SR Capsule Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
ORUVAIL Controlled release capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ORUVAIL Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PEROFEN Coated / Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
PIXICAM Dispersible tablet Health Products Regulatory Authority (ZA) MPI, Generic
PONSTAN FORTE Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PONSTEL Capsule / Tablet / Suspension Health Products Regulatory Authority (ZA) MPI, Generic
PYROCAPS Capsule Health Products Regulatory Authority (ZA) MPI, Generic
RANTUDIL FORTE Hard capsule Medicines Authority (MT) MPI, EU: SmPC
RELAFEN Tablet FDA, National Drug Code (US) MPI, US: SPL/Old
REMETHAN Gastro-resistant tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
REMETHAN Gel Υπουργείο Υγείας (CY) MPI, EU: SmPC
REMETHAN Prolonged-release tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
REMETHAN Suppository Υπουργείο Υγείας (CY) MPI, EU: SmPC
RUPAN FEMME Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
SERACTIL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SOTILEN Capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
STIRLESCENT Effervescent tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SUDAFED NOSE SPRAY Aqueous solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SURGAM Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TAKS Gastro-resistant tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
TAKS Solution for injection or infusion Υπουργείο Υγείας (CY) MPI, EU: SmPC
VELTEX Capsule / Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
VIMOVO Delayed release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
VOLTAROL Medicated Plaster Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VOLTAROL OPTHA MULTIDOSE Eye drops solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VOLTAROL PAIN-EZE EMULGEL Gel for topical administration Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VOLTAROL RAPID Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VOLTAROL Suppositories Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VOLTFAST Powder for oral solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
XEFO Film-coated tablets Health Products Regulatory Authority (IE) MPI, EU: SmPC
XEFO Powder and solvent for solution for injection MPI, EU: SmPC
ZORVOLEX Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR